Retatrutide is a novel glucagon-like peptide-1 receptor agonist. This compound has shown efficacy in managing type 2 diabetes. By mimicking the actions of naturally occurring GLP-1, Retatrutide boosts insulin secretion https://maerfrg362289.aboutyoublog.com/46513969/retatride-a-novel-glucagon-like-peptide-1-receptor-agonist